News Update Cometriq® Approved in Europe

News Update Cometriq® Approved in Europe for the Treatment of Progressive, Unresectable Locally Advanced or Metastatic Medullary Thyroid Carcinoma. http://ow.ly/2F2UoI

Advertisements